Evidence map›Paper›PMID 41450746›Full record

ArticleF1000Research2025

Fostering and sustaining collaborative innovation: Insights from ELIXIR Europe's life science Communities.

Clare Garrard, Katharina F Heil, Maria Cristina Aspromonte, Bérénice Batut, Magda Chegkazi, John M Hancock, Elaine Harrison, Naveed Ishaque, Giselle Kerry, Eija Korpelainen and 11 more

Abstract read
In one paragraph

Article in F1000Research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Clare GarrardELIXIR, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0001-6561-073X
Katharina F HeilELIXIR, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0003-3341-3736
Maria Cristina AspromonteDepartment of Biomedical Sciences, University of Padova, Padova, Italy.
Bérénice BatutIFB-core, IFB, CNRS, INSERM, INRAE, CEA, Institut Français de Bioinformatique, Villejuif, 94800, France.ORCID 0000-0001-9852-1987
Magda ChegkaziELIXIR, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0002-0855-2681
John M HancockInstitute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.ORCID 0000-0003-2991-2217
Elaine HarrisonELIXIR, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0003-1149-2242
Naveed IshaqueBerlin Institute of Health, Center of Digital Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0002-8426-901X
Giselle KerryELIXIR, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Eija KorpelainenCSC - IT Center for Science, Espoo, Finland.ORCID 0000-0002-4406-5602
Jerry LanfearELIXIR, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Corinne MartinELIXIR, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0002-5428-2766
Sebastian SchaafGalaxy Europe, Freiburg Team, Bioinformatics Group, Department of Computer Science, University of Freiburg, Freiburg, Germany.
Serena ScollenELIXIR, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Yun-Yun TsengELIXIR, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Sameer VelankarEMBL-EBI, Wellcome Trust Genome Campus, European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, UK.
Juan Antonio VizcaínoEMBL-EBI, Wellcome Trust Genome Campus, European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, UK.ORCID 0000-0002-3905-4335
Robert M WaterhouseQuartier Sorge, Batiment Amphipole, SIB Swiss Institute of Bioinformatics, Lausanne, 1015, Switzerland.ORCID 0000-0003-4199-9052
Egon WillighagenDepartment of Bioinformatics BiGCaT, NUTRIM, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0001-7542-0286
Niklas BlombergELIXIR, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Peter MaccallumELIXIR, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0001-5260-5915

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Communities of experts collaborating on scientific or technical projects are drivers of innovation across the life sciences. The ELIXIR research infrastructure organises scientific- and technological-themed communities as one of its key mechanisms to ensure that services are user-focused, while at the same time facilitating collaboration and creating scientific impact through the life science data generated across Europe. ELIXIR has rapidly expanded its communities portfolio in response to unmet needs and has developed a comprehensive process framework to facilitate the work of these communities. The ELIXIR Communities framework is made up of a suite of tools and processes that ensure effective community evolution and management, covering how communities are established, led, supported, and can collaborate across ELIXIR and beyond. Being aware of similar approaches in other contexts and in the interests of furthering community development in other research infrastructures and similar organisations, we share insights into the ELIXIR Communities framework and outline the skill set of a community manager and what this looks like in the ELIXIR context. Finally, to show the benefits of the communities, we share concrete examples of how the ELIXIR Communities have had an impact on the scientific landscape. By showcasing these outcomes we hope to demonstrate not only to other research infrastructures, but also to funders, that supporting scientific communities provides a valuable return on investment. We hope that these examples will encourage life scientists who may be interested in joining the ELIXIR Communities, and research infrastructure professionals whose roles require structured engagement with domain experts and users.

Indexed as

Biological Science DisciplinesCooperative BehaviorEuropeHumansBioinformatics ServicesCommunitiesCommunityCommunity ManagementCommunity of practiceDataLife ScienceResearch Infrastructure

Identifiers

PMID41450746
PMCPMC12728338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.